ID   NCE-G 123T2
AC   CVCL_BW89
SY   G123T2
DR   cancercelllines; CVCL_BW89
DR   Wikidata; Q54907659
RX   PubMed=19519771;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N745 ! NCE-G 123
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
RX   PubMed=19519771; DOI=10.1111/j.1471-4159.2009.06027.x;
RA   Eckerich C., Schulte A., Martens T., Zapf S., Westphal M., Lamszus K.;
RT   "RON receptor tyrosine kinase in human gliomas: expression, function,
RT   and identification of a novel soluble splice variant.";
RL   J. Neurochem. 109:969-980(2009).
//